Research Papers

13 of 638 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.
Phan HT; Jager PL; Paans AM; Plukker JT; Sturkenboom MG; Sluiter WJ; Wolffenbuttel BH; Dierckx RA; Links TP.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron em…
Kramer-Marek G; Kiesewetter DO; Martiniova L; Jagoda E; Lee SB; Capala J.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
1/6 Transparent
Funding Declared
Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
Lam MG; Dahmane A; Stevens WH; van Rijk PP; de Klerk JM; Zonnenberg BA.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
1/6 Transparent
Funding Declared
99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated wi…
Hoebers FJ; Kartachova M; de Bois J; van den Brekel MW; van Tinteren H; van Herk M; Rasch CR; Valdés Olmos RA; Verheij M.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
1/6 Transparent
Left ventricular dyssynchrony assessed by two three-dimensional imaging modalities: phase analysis of gated myocardial …
Marsan NA; Henneman MM; Chen J; Ypenburg C; Dibbets P; Ghio S; Bleeker GB; Stokkel MP; van der Wall EE; Tavazzi L; Garcia EV; Bax JJ.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
2/6 Transparent
Funding Declared
Cardiovascular molecular imaging of apoptosis.
Wolters SL; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
Cardiovascular molecular MR imaging.
Lamb HJ; van der Meer RW; de Roos A; Bax JJ.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
Positron detection for the intraoperative localisation of cancer deposits.
Piert M; Burian M; Meisetschläger G; Stein HJ; Ziegler S; Nährig J; Picchio M; Buck A; Siewert JR; Schwaiger M.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2007
1/6 Transparent
Funding Declared
Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies pot…
Eschmann SM; Friedel G; Paulsen F; Reimold M; Hehr T; Scheiderbauer J; Budach W; Kotzerke J; Bares R.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2006
Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
Carlsson J; Eriksson V; Stenerlöw B; Lundqvist H.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2006
1/6 Transparent
Funding Declared
The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatme…
Goerres GW; Stupp R; Barghouth G; Hany TF; Pestalozzi B; Dizendorf E; Schnyder P; Luthi F; von Schulthess GK; Leyvraz S.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2004
Myocardial perfusion scintigraphy: the evidence.
Underwood SR; Anagnostopoulos C; Cerqueira M; Ell PJ; Flint EJ; Harbinson M; Kelion AD; Al-Mohammad A; Prvulovich EM; Shaw LJ; Tweddel AC; British Cardiac Society; British Nuclear Cardiology Society; British Nuclear Medicine Society; Royal College of Physicians of London; Royal College of Radiologists.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2004
1/6 Transparent
Funding Declared
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [1…
Kwekkeboom DJ; Bakker WH; Kam BL; Teunissen JJ; Kooij PP; de Herder WW; Feelders RA; van Eijck CH; de Jong M; Srinivasan A; Erion JL; Krenning EP.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2003